Literature DB >> 19578817

Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.

Andrzej Szkaradkiewicz1, Ryszard Marciniak, Izabela Chudzicka-Strugała, Agnieszka Wasilewska, Michał Drews, Przemysław Majewski, Tomasz Karpiński, Barbara Zwoździak.   

Abstract

INTRODUCTION: The aim of the study was to describe the levels of circulating monocyte/macrophage pro-inflammatory cytokines (TNF-alpha, IL-1beta IL-6, and IL-8) and an anti-inflammatory cytokine (IL-10) in inflammatory bowel disease (IBD) and colorectal cancer (CRC) patients and healthy controls.
MATERIALS AND METHODS: The study was conducted on 15 healthy individuals, 20 patients with ulcerative colitis (UC), 12 with Crohn's disease (CD), and 15 with CRC (Dukes' stage B). Blood serum cytokine levels were measured by ELISA.
RESULTS: The patients with UC had significantly higher levels of the pro-inflammatory cytokines and of circulating IL-10 than the healthy controls. The patients with CD and CRC had the same specific pattern of serum cytokines of significantly elevated levels of the pro-inflammatory cytokines, but the IL-10 levels were within the range found in the healthy individuals.
CONCLUSIONS: Thus our results demonstrate that both IBD and CRC are linked with an intensified production of a wide array of monocyte/macrophage pro-inflammatory cytokines which is not accompanied by elevated levels of circulating IL-10, except for its insufficiently inhibitory elevation in UC patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578817     DOI: 10.1007/s00005-009-0031-z

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  40 in total

1.  Cytokine profiles in peripheral blood of children and adults with Crohn disease.

Authors:  Seung Pak; Nina Holland; Elizabeth A Garnett; Elizabeth Mileti; Uma Mahadevan; Rachel Beckert; Bittoo Kanwar; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-06       Impact factor: 2.839

Review 2.  Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update.

Authors:  Cansel Turkay; Benan Kasapoglu
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

Review 3.  Interleukin-17 SNPs and serum levels increase ulcerative colitis risk: a meta-analysis.

Authors:  Juan Li; Hao Tian; Hui-Jun Jiang; Bin Han
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

4.  Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients.

Authors:  Michel Carlos Mocellin; Juliana de Aguiar Pastore e Silva; Carolina de Quadros Camargo; Maria Emília de Souza Fabre; Scheila Gevaerd; Katya Naliwaiko; Yara Maria Franco Moreno; Everson Araújo Nunes; Erasmo Benicio Santos de Moraes Trindade
Journal:  Lipids       Date:  2013-07-26       Impact factor: 1.880

5.  Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice.

Authors:  Jun Yao; Cheng Wei; Jian-Yao Wang; Ru Zhang; Ying-Xue Li; Li-Sheng Wang
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

6.  Leukocyte populations and IL-6 in the tumor microenvironment of an orthotopic colorectal cancer model.

Authors:  Sarah Miller; Paul V Senior; Monica Prakash; Vasso Apostolopoulos; Samy Sakkal; Kulmira Nurgali
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-17       Impact factor: 3.848

7.  The expression and distribution of group IIA phospholipase A2 in human colorectal tumours.

Authors:  Tuulia Avoranta; Jari Sundström; Eija Korkeila; Kari Syrjänen; Seppo Pyrhönen; Jukka Laine
Journal:  Virchows Arch       Date:  2010-10-12       Impact factor: 4.064

8.  STIM1/ORAI1-mediated Ca2+ Influx Regulates Enolase-1 Exteriorization.

Authors:  Miroslava Didiasova; Dariusz Zakrzewicz; Viktor Magdolen; Chandran Nagaraj; Zoltán Bálint; Manfred Rohde; Klaus T Preissner; Malgorzata Wygrecka
Journal:  J Biol Chem       Date:  2015-03-24       Impact factor: 5.157

9.  Estrogen receptor-β protects against colitis-associated neoplasia in mice.

Authors:  Diana Saleiro; Genoveva Murillo; Richard V Benya; Marc Bissonnette; John Hart; Rajendra G Mehta
Journal:  Int J Cancer       Date:  2012-04-27       Impact factor: 7.396

10.  The Wnt-β-Catenin-IL-10 Signaling Axis in Intestinal APCs Protects Mice from Colitis-Associated Colon Cancer in Response to Gut Microbiota.

Authors:  Daniel Swafford; Arulkumaran Shanmugam; Punithavathi Ranganathan; Indumathi Manoharan; Mohamed S Hussein; Nikhil Patel; Humberto Sifuentes; Pandelakis A Koni; Puttur D Prasad; Muthusamy Thangaraju; Santhakumar Manicassamy
Journal:  J Immunol       Date:  2020-09-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.